ARTICLE | Company News
Sequitur deal
November 22, 1999 8:00 AM UTC
Sequitur announced additional non-exclusive licensees for its Antisense Functional Genomics Technology, which provides antisense compounds, sequence selection and cellular delivery vehicles for use in...